Omri Amirav-Drory, PhD

Omri is a General Partner and head of NFX Bio.  He is a scientist and well-connected leader in biotech who started, invested in, and scaled some of the industry’s most important companies.  Omri founded Genome Compiler, which was later acquired by Twist Bioscience under his guidance.  He has a BS in biochemistry and molecular biology, and a PhD in biochemistry from Tel Aviv University.  Omri was a Fulbright postdoctorate in biochemistry and molecular biology at Stanford University & HHMI.